Target intelligence / Profile preview

Hepatocyte plasma membrane and lipid rafts

Molecular classification
Cellular structure, Membrane microdomain
01

Overview

The hepatocyte plasma membrane is a highly organized cellular boundary that facilitates the liver's diverse metabolic and secretory functions. Lipid rafts are dynamic, cholesterol- and sphingolipid-rich microdomains within this membrane that serve as essential platforms for the assembly of signaling complexes and the regulation of membrane protein trafficking (Lingwood & Simons, 2010, Science). These structures are particularly significant in infectious diseases, as they are exploited by pathogens such as the Hepatitis C virus and Plasmodium species for cellular entry (Kapoor et al., 2011, J Biol Chem; Silvie et al., 2003, Nature Medicine). Additionally, lipid rafts play a role in metabolic signaling, influencing the activity of the insulin receptor and various bile acid transporters like the sodium/taurocholate cotransporting polypeptide (NTCP) (Vial & Schneiter, 2002, Progress in Lipid Research). While the membrane and its rafts are not traditional single-molecule drug targets, they are pharmacologically relevant sites where drugs like cholesterol-depleting agents can disrupt pathological processes (Zhuang et al., 2005, J Lipid Res). However, the therapeutic utility of targeting these domains is limited by a lack of tissue specificity and the risk of interfering with fundamental cellular signaling pathways.

Other names
Hepatic plasma membraneHepatocyte membrane microdomainsDetergent-resistant membranes (DRMs) in hepatocytes
02

Mechanism of action

Disruption of lipid raft assembly through cholesterol depletion or sequestration, thereby inhibiting raft-associated signaling and pathogen entry.

03

Biological functions

Signal transductionEndocytosisViral entryBile acid transportLipid metabolismProtein trafficking
04

Disease associations

InfectionMetabolic diseaseCancerLiver diseaseMalaria
05

Safety considerations

Lack of cell-type specificityDisruption of essential signaling pathwaysPotential for systemic toxicityMembrane instability
06

Interacting drugs

Methyl-beta-cyclodextrin

4 more in the full profile.

07

Biomarkers

Caveolin-1Flotillin-1Membrane cholesterol levels

Beyond the preview

Go deeper on Hepatocyte plasma membrane and lipid rafts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte plasma membrane and lipid rafts.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call